Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines during the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study)

Zoltán Kiss, István Wittmann, Lőrinc Polivka, György Surján, Orsolya Surján, Zsófia Barcza, Gergő Attila Molnár, Dávid Nagy, Veronika Müller, Krisztina Bogos, Péter Nagy, István Kenessey, András Wéber, Mihály Pálosi, János Szlávik, Zsuzsa Schaff, Zoltán Szekanecz, Cecília Müller, Miklós Kásler, Zoltán Vokó
doi: https://doi.org/10.1101/2022.03.27.22273000

Article Information

doi 
https://doi.org/10.1101/2022.03.27.22273000
History 
  • March 30, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Zoltán Kiss1,†,
  2. István Wittmann1,†,
  3. Lőrinc Polivka2,
  4. György Surján3,
  5. Orsolya Surján4,
  6. Zsófia Barcza5,
  7. Gergő Attila Molnár1,
  8. Dávid Nagy6,7,
  9. Veronika Müller2,
  10. Krisztina Bogos8,
  11. Péter Nagy9,
  12. István Kenessey9,10,
  13. András Wéber9,10,
  14. Mihály Pálosi12,
  15. János Szlávik13,
  16. Zsuzsa Schaff14,
  17. Zoltán Szekanecz15,
  18. Cecília Müller16,
  19. Miklós Kásler3,†† and
  20. Zoltán Vokó6,7,††,*
  1. 1Second Department of Medicine and Nephrology-Diabetes Center, University of Pécs Medical School, Pécs, Hungary
  2. 2Department of Pulmonology, Semmelweis University, Budapest, Hungary
  3. 3Ministry of Human Resources, Budapest, Hungary
  4. 4Department of Deputy Chief Medical Officer II., National Public Health Center, Budapest, Hungary
  5. 5Syntesia Medical Communications Ltd., Budapest, Hungary
  6. 6Center for Health Technology Assessment, Semmelweis University, Budapest
  7. 7Syreon Research Institute, Budapest, Hungary
  8. 8Department of Pulmonology, National Korányi Institute of Pulmonology, Budapest, Hungary
  9. 9National Institute of Oncology, Budapest, Hungary
  10. 10Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France
  11. 11Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary
  12. 12National Health Insurance Fund, Budapest, Hungary
  13. 13South-Pest Hospital Centre – National Institute for Infectology and Haematology, Budapest, Hungary
  14. 14Department of Pathology, Semmelweis University, Budapest, Hungary
  15. 15Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
  16. 16Department of Chief Medical Officer, National Public Health Center, Budapest, Hungary
  1. ↵*Correspondence:
    Prof. Dr. Zoltan Vokó, Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary; H-1091 Budapest Üllői út 25. Phone: +36 30 992 7628, Email: voko.zoltan{at}semmelweis-univ.hu

  1. ↵† These authors contributed equally to this work and share first authorship

  2. ↵†† These authors contributed equally to this work and share senior authorship

Back to top
Posted March 30, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines during the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study)
Zoltán Kiss, István Wittmann, Lőrinc Polivka, György Surján, Orsolya Surján, Zsófia Barcza, Gergő Attila Molnár, Dávid Nagy, Veronika Müller, Krisztina Bogos, Péter Nagy, István Kenessey, András Wéber, Mihály Pálosi, János Szlávik, Zsuzsa Schaff, Zoltán Szekanecz, Cecília Müller, Miklós Kásler, Zoltán Vokó
medRxiv 2022.03.27.22273000; doi: https://doi.org/10.1101/2022.03.27.22273000
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area